Abbott Laboratories Profile


Odds of Distress

Analyze Filter    Fiscal Quarter End: December 31, 2019
Equity ratings for Abbott Laboratories are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting September 8, 2019 and ending today December 7, 2019. Click here to learn more.

Abbott Laboratories Profile

Next fiscal quarter end is expected on December 31, 2019. Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company was founded in 1888 and is headquartered in Abbott Park, Illinois. Abbott Laboratories operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 103000 people. more
Abbott Laboratories Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Abbott Laboratories SEC Filings
Abbott Laboratories SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameAbbott Laboratories
ChairmanMiles WhiteView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 4 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Medical Devices
InstrumentUSA Stock View All
RegionNorth America
LocationIllinois; U.S.A
Business Address100 Abbott Park Road
Foreign Associate  Austria
ExchangeBATS Exchange
CIK Number0000001800
IndustryMedical Devices
Phone224 667 6100
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterSeptember 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestNovember 15, 2019
Abbott Laboratories (ABT) is traded on BATS Exchange in USA. It is located in 100 Abbott Park Road and employs 103,000 people. Abbott Laboratories is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with total capitalization of 149.39 B. Abbott Laboratories runs under Healthcare sector within Medical Devices industry. The entity has 1.77 B outstanding shares of which 17.5 M shares are presently shorted by investors with about 3.45 days to cover shorted positions. ABBOTT LABORATORI has about 4.34 B in cash with 3.58 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.45.
Check Abbott Laboratories Probability Of Bankruptcy

Ownership Allocation (%)

Abbott Laboratories Target Price Odds Analysis

Odds Below 85.18HorizonTargetOdds Above 85.18
88.25%30 days 85.18 11.50%
Based on normal probability distribution, the odds of Abbott Laboratories to move above current price in 30 days from now is about 11.5 (This Abbott Laboratories probability density function shows the probability of Abbott Laboratories Stock to fall within a particular range of prices over 30 days) .

Abbott Laboratories Top Holders

Abbott Laboratories Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares150 M12.6 B
Blackrock IncCommon Shares127.9 M10.7 B
View Abbott Laboratories Diagnostics

Abbott Laboratories Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Abbott Laboratories Key Fundamentals

Abbott Laboratories Against Markets

Did you try this?

Run Portfolio Center Now


Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module

Abbott Laboratories Upcoming and Recent Events

Abbott Laboratories Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportJanuary 22, 2020
Next Earnings ReportApril 15, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndJanuary 22, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Abbott Laboratories Corporate Filings

Abbott Laboratories SEC Reporting

Financial Statements and Exhibits. Other Events
Other Events
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Unclassified Corporate Event

Abbott Laboratories Distributions to stockholders

Abbott Laboratories Corporate Directors

Samuel Scott Independent Director
Nancy McKinstry Independent Director
James Farrell Independent Director
Check also Trending Equities. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.